Clinical use of hd-mtx monotherapy in a rare case of refractory primary bone diffuse large b-cell lymphoma with long-term survival after local radiotherapy: a case report

HIGHLIGHTS

  • who: Zhiya Wu from the University of Patras, Greece have published the research work: Clinical use of HD-MTX monotherapy in a rare case of refractory primary bone diffuse large B-cell lymphoma with long-term survival after local radiotherapy: A case report, in the Journal: (JOURNAL)
  • what: To enrich the experience in the treatment of PBL, the authors report a case of PB-DLBCL on HD-MTX monotherapy after multi-line treatment failure, through which the patient recovered from paralysis and achieved long-term survival for more than 10 years. This study showed no . . .

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?